Konstantin Petrukhin

Title: Innovations of Konstantin Petrukhin

Introduction

Konstantin Petrukhin is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of genetics, particularly in the study of macular dystrophies. With a total of three patents to his name, Petrukhin's work has the potential to impact the understanding and treatment of eye diseases.

Latest Patents

One of his latest patents involves the identification of the gene responsible for Stargardt-like dominant macular dystrophy. This discovery includes the normal allelic form of the gene, which encodes a mutant protein containing a frameshift mutation. This mutation results in abnormal fatty acid synthesis and transport in the retina. Additionally, the patent discloses assays for Stargardt-like macular dystrophy and potential therapies.

Career Highlights

Petrukhin is currently employed at Merck & Company, Inc., where he continues to advance his research in genetics and ophthalmology. His work at Merck has allowed him to collaborate with leading experts in the field, further enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include Wen Qian Li and Kang Zhang. Their collaborative efforts contribute to the innovative research environment at Merck, fostering advancements in genetic therapies.

Conclusion

Konstantin Petrukhin's contributions to the field of genetics, particularly in relation to macular dystrophies, highlight the importance of innovation in medical research. His patents and ongoing work at Merck & Company, Inc. demonstrate a commitment to improving the understanding and treatment of eye diseases.